Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Biliary Tract Diseases

  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 25 articles:
HTML format

Single Articles

    August 2021
  1. XU J, Bai Y, Sun H, Bai C, et al
    A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33803.
    PubMed     Abstract available

    July 2021
    A noticeable absence.
    Cancer. 2021;127:2397-2398.
    PubMed     Abstract available

    March 2021
  3. OUYANG G, Liu Q, Wu Y, Liu Z, et al
    The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Cancer. 2021 Mar 22. doi: 10.1002/cncr.33476.
    PubMed     Abstract available

    December 2020
  4. KAMARAJAH SK, Bednar F, Cho CS, Nathan H, et al
    Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Cancer. 2020 Dec 15. doi: 10.1002/cncr.33356.
    PubMed     Abstract available

  5. TAN ES, Cao B, Kim J, Al-Toubah TE, et al
    Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
    Cancer. 2020 Dec 8. doi: 10.1002/cncr.33364.
    PubMed     Abstract available

    May 2020
  6. KIM RD, Sanoff HK, Poklepovic AS, Soares H, et al
    A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer.
    Cancer. 2020 May 26. doi: 10.1002/cncr.32964.
    PubMed     Abstract available

    March 2020
  7. FLORIO AA, Ferlay J, Znaor A, Ruggieri D, et al
    Global incidence of and trends in intrahepatic and extrahepatic cholangiocarcinoma from 1993 to 2012.
    Cancer. 2020 Mar 4. doi: 10.1002/cncr.32803.
    PubMed     Abstract available

    February 2020
  8. MAYNARD H, Stadler ZK, Berger MF, Solit DB, et al
    Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.
    Cancer. 2020 Feb 3. doi: 10.1002/cncr.32740.
    PubMed     Abstract available

    August 2019
  9. LOWERY MA, Goff LW, Keenan BP, Jordan E, et al
    Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
    Cancer. 2019 Aug 27. doi: 10.1002/cncr.32463.
    PubMed     Abstract available

    July 2019
  10. SASAKI CT, Doukas SG, Costa J, Vageli DP, et al
    Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.
    Cancer. 2019 Jul 16. doi: 10.1002/cncr.32369.
    PubMed     Abstract available

    May 2019
  11. SHARMA MR, Joshi SS, Karrison TG, Allen K, et al
    A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
    Cancer. 2019;125:1629-1636.
    PubMed     Abstract available

  12. WONG W, Lowery MA, Berger MF, Kemel Y, et al
    Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.
    Cancer. 2019;125:1441-1448.
    PubMed     Abstract available

    January 2019
  13. VAN DYKE AL, Shiels MS, Jones GS, Pfeiffer RM, et al
    Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31942.
    PubMed     Abstract available

    December 2018
  14. SUN W, Patel A, Normolle D, Patel K, et al
    A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31872.
    PubMed     Abstract available

    November 2018
  15. NARAYAN RR, Creasy JM, Goldman DA, Gonen M, et al
    Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
    Cancer. 2018 Nov 14. doi: 10.1002/cncr.31850.
    PubMed     Abstract available

    December 2017
  16. MOMENI-BOROUJENI A, Yousefi E, Somma J
    Computer-assisted cytologic diagnosis in pancreatic FNA: An application of neural networks to image analysis.
    Cancer. 2017;125:926-933.
    PubMed     Abstract available

    August 2017
  17. TRAN CAO HS, Zhang Q, Sada YH, Chai C, et al
    The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30968.
    PubMed     Abstract available

    July 2017
  18. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Abstract available

    June 2017
  19. WALTERHOUSE DO, Pappo AS, Meza JL, Breneman JC, et al
    Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Cancer. 2017;123:2368-2375.
    PubMed     Abstract available

    May 2017
  20. GULHATI P, Raghav K, Shroff RT, Varadhachary GR, et al
    Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Cancer. 2017;123:1011-1017.
    PubMed     Abstract available

  21. ROSENBAUM MW, Cauley CE, Kulemann B, Liss AS, et al
    Cytologic characteristics of circulating epithelioid cells in pancreatic disease.
    Cancer. 2017;125:332-340.
    PubMed     Abstract available

    February 2017
  22. GOYAL L, Zheng H, Yurgelun MB, Abrams TA, et al
    A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncr.30571.
    PubMed     Abstract available

    December 2016
  23. YAMASHITA S, Koay EJ, Passot G, Shroff R, et al
    Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients.
    Cancer. 2016 Dec 16. doi: 10.1002/cncr.30488.
    PubMed     Abstract available

    October 2016
    Cancer Cytopathology: 20 years of advancing the field of pancreaticobiliary cytopathology.
    Cancer. 2016;124:690-694.

    September 2016
  25. JAVLE M, Bekaii-Saab T, Jain A, Wang Y, et al
    Biliary cancer: Utility of next-generation sequencing for clinical management.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30254.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.